Research IT Partnership with Nycomed Expands Genedata`s Business Model |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Genedata AG
Maulbeerstrasse 46
Basel, CH-4016
Switzerland
Press release date: November 20, 2007
Basel, Switzerland
November 20, 2007 -- Swiss-based drug discovery informatics provider Genedata AG today announced the establishment of a novel research IT alliance with Nycomed, a global leader in innovative pharmaceuticals.
An increasing number of pharmaceutical companies are outsourcing their research IT services to specialized partners in order to increase focus on their core competencies, drive IT innovation and subsequently improve IT performance and reduce overall R&D costs. In line with this trend and Nycomed`s new R&D operating model, Genedata and Nycomed are establishing a strategic partnership that will capitalize on Genedata`s extensive technological expertise to support Nycomed`s proprietary R&D data and knowledge management.
The existing Nycomed research IT infrastructure will be adapted to the new R&D operating model, with Genedata supporting Nycomed in developing and implementing scientific databases and applications for research data management and scientific analysis. The implementation of novel solutions and more efficient workflows is key in this effort. To enhance the smooth integration of Genedata's expertise into the R&D operations of Nycomed, Genedata has established an office on location, at the Nycomed site in Konstanz, Germany.
"Our new R&D strategy and operating model is aiming for a highly flexible organization that focuses on its core competencies to fill our pipeline with medicines that have true medical utility. For this we were seeking an outsourcing partner able to provide superior technology as well as expertise, and launch quality solutions in a short span of time," explained Dr. Karl Zech, Senior Vice President Discovery and Proof of Concept Development at Nycomed. "In addition, effective partnering requires an established, trusting and highly interactive relationship, which makes Genedata a distinguished first choice."
Dr. Othmar Pfannes, CEO of Genedata AG, said: "We are delighted and committed to take a prolific long-term collaboration to an even higher level, supporting Nycomed to leverage in-house resources and gain competitive advantage. Taking on operational responsibilities represents a new Genedata business approach, that, in complexity and scope, goes beyond the customary provision of software products and services."
Contact Genedata Christiane Becker Public Relations Phone +41 61 697 7378 Fax +41 61 697 7244 christiane.becker@genedata.com www.genedata.com
Contact Nycomed Dr. Martin Zoche Senior Project Manager, Support & Operations Phone: +49 7531 84 4506 Fax: +49 7531 849 4506 martin.zoche@nycomed.com www.nycomed.com
Nycomed is a pharmaceutical company that provides medicines for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets. The company is active within a range of therapeutic areas, including cardiology, gastroenterology, osteoporosis, respiratory, pain and tissue management. New products are sourced both from own research and from external partners. Operating throughout Europe and in fast-growing markets such as Latin America, Russia/CIS and the Asia-Pacific region Nycomed has a presence in about 50 markets worldwide. Privately owned, the combined group had annual sales of approximately 3.4 billion and an EBITDA of 933.4 million (2006 results). For more information visit www.nycomed.com
Genedata AG specializes in discovery informatics for biotech, pharmaceuticals and the life sciences. The company offers expertise in research informatics combined with open and scalable computational solutions. Our product suites include Genedata Phylosopher® for integrating, structuring, and analyzing research data, Genedata Screener® for high throughput screening analysis, and Genedata Expressionist® for omics data integration, processing and analysis. Founded in 1997 as a privately held spin-off from Novartis, Genedata is headquartered in Basel, Switzerland, and has branches in Munich (Germany), Konstanz (Germany), Boston (USA), San Francisco (USA), and Tokyo (Japan). The company is also represented in Taiwan and Singapore. For more information visit www.genedata.com
Genedata AG Maulbeerstrasse 46 4016 Basel Switzerland Tel. +41 61 697 6099 Fax +41 61 697 7244 communications@genedata.com
www.genedata.com
|
|
|
|
|
|
| 
